Aurolife Pharma recalls 1 mg Glycopyrrolate tablets due to failed impurities tests. These prescription drugs may contain harmful substances. Consumers should contact the manufacturer for details.
“Aurolife Glycopyrrolate Tablets Recall: Impurities Risk Serious Harm.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33436-aurolife-glycopyrrolate-tablets-recall-impurities-risk-serious-harm. Based on FDA recall #D-0877-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0877-2023%22&limit=1).
The FDA announced on May 18, 2023, that Aurolife Pharma, LLC is recalling Glycopyrrolate Tablets, USP, 1 mg, due to failed impurities and degradation specifications. The Class III recall affects distributed bottles from Aurobindo Pharma USA, Inc.
The recall is due to failed impurities and degradation specifications in the tablets, according to the FDA.
Context
GovInfoNow's records show Aurolife Pharma, LLC has issued three other recalls since August 23, 2019. Other recent recalls of similar products include Novadoz Glycopyrrolate Oral Solution Recall (December 15, 2025), Precision Dose Glycopyrrolate Oral Solution Recall (July 14, 2026), and Ajanta Pharma Fluphenazine Tablets Recall (August 25, 2026).
How to tell if you have this one
Check for 100-count bottles labeled 'Glycopyrrolate Tablets, USP, 1 mg' with NDC 13107-014-01 and lot number 01421038A1. These were distributed by Aurobindo Pharma USA, Inc. in East Windsor, NJ.
Brand
Aurolife
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the NDC code 13107-014-01 and lot number 01421038A1 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 15 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0877-2023 (May 18, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0877-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.